Clinical Trials Logo
  1. Home
  2. Craniopharyngioma
  3. NCT04937335
  4. Details
NCT04937335 Clinical Trial

Craniopharyngioma With Tumoral Hemorrhage

Craniopharyngioma Clinical Trial

Official title:
Clinical Features and Risk Factors of Craniopharyngioma With Tumoral Hemorrhage

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04937335
Other study ID # kaishu1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2013
Est. completion date February 1, 2021

Study information
Verified date June 2021
Source Tongji Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Clinical data of 185 consecutive patients receiving resective operation with a pathological diagnosis of craniopharyngioma in our hospital between January 2013 and February 2021 were collected. Among these patients, 18 of them were recognized as craniopharyngioma with tumoral hemorrhage during the operation.

Description:

For each case, age, gender, smoking status, alcohol intake, past history, symptoms, blood pressure, blood cell count, blood biochemical tests, coagulation tests, hormone tests, radiological results, surgical treatment and the outcome at discharge were collected. The first test result after admission and before the operation was taken for the items of blood tests with multiple times in the analysis.

Recruitment information / eligibility
Status Completed
Enrollment 185
Est. completion date February 1, 2021
Est. primary completion date February 1, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - receive resective operation with a pathological diagnosis of craniopharyngioma in our hospital - enter our hospital between January 2013 and February 2021 Exclusion Criteria: - have a non-craniopharyngioma or unverified pathological diagnosis at discharge - have received surgical or radiological treatment on the sellar region - receive treatment of coagulation modulation, immunosuppressive agents or chemotherapeutic drugs - combine with other clinical emergencies including acute myocardial infarction, cerebral stroke, trauma and sepsis at admission - have been diagnosed with other tumors, hematological diseases, autoimmune diseases, liver failure or renal failure

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• intratumoral hemorrhage
Patients who were recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation were enrolled in the hemorrhage group.

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Tongji Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary craniopharyngioma with tumoral hemorrhage Current study is a case-control study whose primary outcome is tumoral hemorrhage observed during the operation, which devided the craniopharyngioma patients into hemorrhage group and non-hemorrhage group. during the operation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00949156 - Tumor Classification and Its Application in Surgical Treatment of Craniopharyngioma Phase 1
Recruiting NCT05465174 - Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults Phase 2
Recruiting NCT05525273 - Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma Phase 2
Completed NCT02849743 - Intranasal Oxytocin in Hypothalamic Obesity Phase 2
Completed NCT01272622 - Prospective Study of Children and Adolescents With Craniopharyngioma N/A
Recruiting NCT04158284 - Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
Completed NCT03194906 - Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors Phase 2
Recruiting NCT06217848 - The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study Early Phase 1
Completed NCT01881854 - Sleep Wake and Melatonin Pattern in Craniopharyngioma N/A
Active, not recruiting NCT00517959 - SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors Phase 3
Not yet recruiting NCT06299891 - Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity Phase 2
Completed NCT02842723 - Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma) Phase 2
Recruiting NCT02792582 - A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection Phase 2
Completed NCT01484873 - Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor Phase 2
Withdrawn NCT03708913 - Neuromodulation for Hypothalamic Obesity N/A
Completed NCT02162732 - Molecular-Guided Therapy for Childhood Cancer N/A
Recruiting NCT00840047 - Methionine PET/CT Studies In Patients With Cancer Phase 2
Recruiting NCT04087902 - Long-Term Longitudinal QoL in Patients Undergoing EEA
Recruiting NCT04648462 - Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Completed NCT03330080 - Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients